Page 9 - நொதி News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from நொதி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In நொதி Today - Breaking & Trending Today
New substance suppresses the growth of harmful bacteria that cause periodontitis Targeted, efficient and with few side effects: A new method for combating periodontitis could render the use of broad-spectrum antibiotics superfluous. It was developed and tested for the first time by a team from Martin Luther University Halle-Wittenberg (MLU), the Fraunhofer Institute for Cell Therapy and Immunology IZI and Periotrap Pharmaceuticals GmbH. The aim is to neutralize only bacteria that cause periodontitis while sparing harmless bacteria. The study appeared in the Journal of Biological Chemistry. Periodontitis is a common bacterial inflammation of the gums. According to the World Health Organization WHO Oral Health Study, almost 10 percent of the global population are affected with a severe form of the disease, which can lead to tooth loss as well as increasing the risk of other diseases, such as Alzheimer s and cardiovascular disease. Until now, treatment has mainly involve ....
Novel host-viral-microbiome interactions during COVID-19 may determine outcome The current pandemic of coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been spreading rapidly for over a year. Though primarily a respiratory illness, its manifestations are often protean and may be life-threatening. A new preprint on the medRxiv server discusses how the underlying disease mechanisms are regulated such that the local or mucosal immune response is distinct from the systemic response. Viral suppression of innate but not adaptive immunity The initial infection of epithelial cells in the upper respiratory tract, via the angiotensin-converting enzyme 2 (ACE2), triggers early innate defenses that prevent replicative infection and progressive disease. ....
Researchers found a small molecule that inhibits different virus proteins and significantly reduces infection in cells. Combined with the antiviral remdesivir, its potency increases significantly, suggesting it may be a potential antiviral candidate for the treatment of COVID-19. ....
Scientists reprogram a common bacterium to make designer sugar-based drug Envisioning an animal-free drug supply, scientists have -; for the first time -; reprogrammed a common bacterium to make a designer polysaccharide molecule used in pharmaceuticals and nutraceuticals. Published today in Nature Communications, the researchers modified E. coli to produce chondroitin sulfate, a drug best known as a dietary supplement to treat arthritis that is currently sourced from cow trachea. Genetically engineered E. coli is used to make a long list of medicinal proteins, but it took years to coax the bacteria into producing even the simplest in this class of linked sugar molecules -; called sulfated glycosaminoglycans -;that are often used as drugs and nutraceuticals.. ....
Researchers at the New York State Department of Health in the United States have said concerning mutations within the B.1.526 lineage of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that has recently become prevalent in New York State warrant further monitoring. ....